Victor Shi, MD
Vascular & Interventional Radiology · Montebello, CANPI 1770857427
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,389 of the $6,679 with a category attached, or 80.7%. 11 manufacturers reported payments, led by Angiodynamics, Inc. at 33.5% of the total. Reporting peaked in 2024 at $2,553 and has fallen 75.0% since, to $637 in 2025.
Across 137 payments — averaging $48.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$2K
- Sirtex Medical Inc$2K
- Terumo Medical Corporation$731
- Boston Scientific$690
- Abbott$586
- Bard Peripheral Vascular, Inc.$316
- plus $534 from 5 others
What the payments were for
- Travel & lodging$1,29019%
- Food & beverage$5,38981%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 46 | $2,236 |
| Sirtex Medical Inc | 11 | $1,587 |
| Terumo Medical Corporation | 5 | $731 |
| Boston Scientific | 13 | $690 |
| Abbott | 32 | $586 |
| Bard Peripheral Vascular, Inc. | 9 | $316 |
| Philips North America LLC | 16 | $275 |
| Asahi Intecc USA, Inc. | 1 | $105 |
| Guerbet LLC | 1 | $95 |
| Cardiovascular Systems Inc. | 2 | $36 |
| Tactile Systems Technology Inc | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,679 in reported general payments places this provider in the 65th percentile of 504 vascular & interventional radiology providers in California.
See all vascular & interventional radiology providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 66 | $329 |
| Methylprednisolone | 12 | $82 |
| Ciprofloxacin Hcl | 12 | $35 |
| Ibuprofen | 14 | $22 |
| Prednisone | 12 | $11 |
Paid to pharmacies, not to this prescriber.
Other vascular & interventional radiology in Montebello
- Salar HakhamMontebello$225K
- Mahmood RazaviOrange$2.4M
- Keith TerasakiLos Angeles$1.7M
- Bart DolmatchMountain View$1.7M
- Edward LeeLos Angeles$1.4M
- Alexander MisonoNewport Beach$1.3M
- Kevin BurnsOrange$1.1M
- Siddharth PadiaLos Angeles$960K
- Satoshi TateshimaLos Angeles$764K
- Blaise BaxterSan Francisco$757K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.